Background. Lung injury is a life-threatening complication in patients with liver dysfunction. We recently provided an experimental lung injury model in mouse with common bile duct ligation. In this study, we aimed to characterize the pathologic and biochemical features of lung tissues in common bile duct ligation mice using a proteomic approach. Methods. Common bile ducts of BALB/c mice, 8 weeks of age, were ligated operatively. CD31-expressing pulmonary cells were sorted with immunomagnetic microbeads, and protein profiles were examined by 2-dimensional gel electrophoresis. Based on the results of protein identification, immunohistochemistry and quantitative reverse transcription polymerase chain reaction were carried out in pulmonary and hepatic tissues. Results. Two-dimensional gel electrophoresis revealed 3 major inflammation-associated proteins exhibiting considerable increases in the number of CD31-positive pulmonary cells after common bile duct ligation. Mass spectrometry analysis identified these proteins as SerpinB1a (48 kDa), ANXA1 (46 kDa), and S100A9 (16 kDa). Furthermore, the 3 proteins were more highly expressed in dilated pulmonary blood vessels of common bile duct ligation mice, in which neutrophils and monocytes were prominent, as shown by immunohistochemistry. More importantly, SerpinB1a mRNA and protein were significantly upregulated in the liver, whereas S100A9 and ANXA1 mRNA and protein were upregulated in the lungs, as shown by quantitative reverse transcription polymerase chain reaction and Western blotting. Conclusion. We identified 3 proteins that were highly expressed in the lung after common bile duct ligation using a proteomics-based approach. (Surgery 2017;161:1525-35.) 
Background. Lung injury is a life-threatening complication in patients with liver dysfunction. We recently provided an experimental lung injury model in mouse with common bile duct ligation. In this study, we aimed to characterize the pathologic and biochemical features of lung tissues in common bile duct ligation mice using a proteomic approach. Methods. Common bile ducts of BALB/c mice, 8 weeks of age, were ligated operatively. CD31-expressing pulmonary cells were sorted with immunomagnetic microbeads, and protein profiles were examined by 2-dimensional gel electrophoresis. Based on the results of protein identification, immunohistochemistry and quantitative reverse transcription polymerase chain reaction were carried out in pulmonary and hepatic tissues. Results. Two-dimensional gel electrophoresis revealed 3 major inflammation-associated proteins exhibiting considerable increases in the number of CD31-positive pulmonary cells after common bile duct ligation. Mass spectrometry analysis identified these proteins as SerpinB1a (48 kDa), ANXA1 (46 kDa), and S100A9 (16 kDa). Furthermore, the 3 proteins were more highly expressed in dilated pulmonary blood vessels of common bile duct ligation mice, in which neutrophils and monocytes were prominent, as shown by immunohistochemistry. More importantly, SerpinB1a mRNA and protein were significantly upregulated in the liver, whereas S100A9 and ANXA1 mRNA and protein were upregulated in the lungs, as shown by quantitative reverse transcription polymerase chain reaction and Western blotting. Conclusion. We identified 3 proteins that were highly expressed in the lung after common bile duct ligation using a proteomics-based approach. ( [3] [4] [5] In such cases, severe hypoxemia due to increased pulmonary capillary permeability is often observed. Moreover, similar lung injury pathology has been investigated experimentally in a porcine model of acute liver failure. 6 These studies have shown that lung injury after liver injury can cause fatal complications, such as severe desaturation in blood and intrapulmonary bleeding. 1 Therefore, there is an urgent need to establish effective medical approaches for managing lung damage.
In a recent study, we established an experimental murine lung injury model induced by common bile duct ligation (CBDL) and observed dilated vessels and angiogenesis in lungs after operation. 7 Immunohistologic analyses and gene expression profiling in pulmonary cells revealed a significant increase in CD31-positive vascular endothelial cells 2-3 weeks after CBDL, with modulation of 19 genes encoding angiogenesisregulating factors. Notably, the lung pathology and gene expression patterns in our murine model showed significant differences compared with those in rat models, with regard to DNA microarray data. For example, in our mouse model, we found that tumor necrosis factor (TNF)-a signaling was strongly activated in proliferating CD31-positive pulmonary cells and played an important role in the development of pulmonary injuries and consequent vascular endothelial growth factor-independent angiogenesis. 7 In this study, we investigated protein profiles in the lungs of CBDL mice, using a proteomic approach to obtain further insights into the molecular mechanisms underlying lung injury in patients with acute liver failure. Our findings may contribute to the development of medical treatments for lung injuries associated with cholestatic liver injury.
MATERIALS AND METHODS
Mouse model of CBDL. All mice were operated on and cared for following the animal protocols approved by the Ehime University Animal Care Committee (approval number: 05R02-2). Fifty-five Balb/c mice (8 weeks old) were purchased from Clea Japan Inc (Tokyo, Japan). Mice were provided a sterilized diet and water ad libitum. Common bile duct ligation and sample collection were performed as previously described. 7 Briefly, the common bile duct was dissected, doubly ligated with commercially available surgical sutures (7-0 Prolene sutures; Ethicon, Somerville, NJ), and divided into groups.
In control mice, dissection around the common bile duct was performed. All surviving mice were died between 2 and 4 weeks after operation. Before death, mice were anesthetized using a combination of ketamine (0.1 mg/g) and xylazine (0.01 mg/g) in phosphate-buffered saline (PBS). Under complete sedation, mice were subcutaneously injected with 50 IU heparin sodium. The trachea was cannulated using a 20-G Terumo Surflo Catheter (Terumo Corporation, Japan) to inflate the lungs. Pulmonary arteries were irrigated with 10 mL cold PBS and drained via the operatively opened right atrial appendage. After the inflation, the lungs were fixed at 23 cm pressure, using 4% paraformaldehyde. The other organs (hearts, livers, and spleens) were removed carefully for subsequent experiments.
Isolation of CD31-positive cells using magnetic beads. CD31-positive pulmonary cells were purified as described previously. 7 Briefly, pulmonary tissues were obtained and digested with 400 U/ mL collagenase type I (Worthington, Lakewood, NJ). Antimouse CD31 antibody (BD Biosciences, San Diego, CA) was conjugated with Dynabeads Sheep antirat IgG (Life Technologies, Grand Island, NY). The digested tissues were passed through a 70-mm mesh filter and gently centrifuged. The pellet was suspended with Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (Wako Pure Chemical Industries, Osaka, Japan). The cells were mixed with anti-CD31 antibody-coated magnetic beads and then incubated for 20 min at 48C. CD31-positive pulmonary cells were washed with DMEM.
Two-dimensional (2D) gel electrophoresis. 2D gel electrophoresis was performed as previously described (Fig 1, A) . 8 Briefly, the purified CD31-positive pulmonary cells were lysed with urea lysis buffer containing 8.5 M urea, 4% CHAPS, and 0.2% Biolyte 3/10 (Bio-Rad Laboratories, Hercules, CA) for 2D gel electrophoresis. Cell lysates containing 20 mg total proteins were separated using Immobiline Dry Strips (13 cm in length, pH 3-10; GE Healthcare, Buckinghamshire, UK). Subsequently, as a second dimension, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out using 10% acrylamide gels. Proteins were visualized with SyproRuby (Invitrogen, Carlsbad, CA).
In-gel digestion and mass spectrometry (MS). In-gel tryptic digestion was performed as previously described. 9 After excised protein spots from 2D gels were digested with trypsin, the cleaved peptides were extracted from the gels using 50% (v/v) acetonitrile/5% (v/v) trifluoroacetic acid. The molecular mass of each peptide was measured using a matrix-assisted laser desorption ionization (MALDI)-time-of-flight (TOF)/TOF mass spectrometer (Shimadzu AXIMA-TOF2; Shimadzu, Japan). The obtained data were analyzed using the MASCOT program (Matrix Science, London, UK) to identify protein candidates for each spot. Database searches were carried out against the Swiss Prot 2015-12 database (550,116 sequences; 196,219,159 residues).
Immunohistochemistry. Tissues, including the lung and liver, were harvested, fixed in 4% paraformaldehyde buffered in PBS, embedded in paraffin, and sectioned at 5-mm thickness. Immunohistochemical staining of these tissue sections was then carried out as described previously. 10 In brief, the sections were blocked with 10% normal goat serum (Nichirei, Tokyo, Japan), incubated with primary antibodies against SerpinB1, ANXA1 (Santa Cruz Biotechnology, Santa Cruz, CA), and S100A9 (Novus Biologicals, Littleton, CO), and probed with biotinylated secondary antibodies.
The sections were stained with 3,39-diaminobenzidine (DAB; Sigma-Aldrich, St. Louis, MO) according to the manufacturer's instructions. Images were then acquired using a phase-contrast microscope (BX51; Olympus, Tokyo, Japan). The area ratio of the DAB-stained region was measured under high magnification (4003), using BZ Image Measurement Software (KEYENCE, Osaka, Japan). The samples were chosen from each group by blinded observers, and the entire analysis was carried out in a blinded manner.
Quantitative reverse transcriptional polymerase chain reaction (qRT-PCR). Tissues were homogenized in Isogen II (Nippon Gene, Toyama, Japan). After total RNA was extracted using TRIzol Reagent (Invitrogen), one microgram of RNA was reverse transcribed using a High Capacity RNA-tocDNA Master Mix (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. Subsequently, real-time PCR was carried out (FastStart Universal SYBR Green Master ROX; Roche Diagnostics, Basel, Switzerland) with an ABI 7300/ 7500 Real-Time PCR system (Applied Biosystems). SerpinB1a, ANXA1, and S100A9 mRNA levels were divided by the levels of b-actin mRNA.
The primers used for PCR were as follows: CATCTTCTTCTCTCCCTTCAGC (SerpinB1a-f) and GAGTGTGAGATGCTCCACGT (SerpinB1a-r) for SerpinB1a, ACTCCAGCTTTCTTTGCCGA (ANXA1-f) and CAATTTCCGAACGGGAGACC (ANXA1-r) for ANXA1, CGGTTCCGATGCCCT-GAGGCTCTT (b-actin-f) CGTCACACTTCAT-GATGGAATTGA (b-actin-r) for b-actin, and GTCCAGGTCCTCCATGATGT (S100A9-f) and GAAGGAAGGACACCCTGACA (S100A9-r) for S100A9. All experiments were carried out in triplicate and separately repeated at least 3 times.
Western blot analysis. Twenty micrograms of protein, isolated from each tissue homogenate with SDS lysis buffer containing 50 mM Tris-HCl (pH 7.4), 0.1% SDS, 1% Nonidet P-40, 1 mM EDTA, 1% sodium cholate, 0.15 M NaCl, and 0.5 mM phenylmethylsulfonyl fluoride, was subjected to SDS-PAGE. The proteins were transferred electrophoretically to polyvinylidene fluoride (PVDF) membranes (Bio-Rad Laboratories). Subsequently, the membranes were probed with primary antibodies against SerpinB1a, ANXA1, S100A9, and b-actin, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Antibody binding was visualized using an ECL detection kit (GE Healthcare, Buckinghamshire, UK), and images were acquired using a LAS-4000 system (Fujifilm Life Science USA, Stamford, CT).
Statistical analysis. Data were based on a minimum of 3 independent experiments. The results are represented as means ± standard errors (SEs). Two groups were compared by Student t tests. Statistical analyses were carried out using GraphPad software (GraphPad Prism; GraphPad Software, San Diego, CA).
RESULTS
Identification of CBDL-induced proteins in lungs. Two-dimensional gel electrophoresis showed that the levels of 3 different proteins were significantly increased in isolated CD31-positive pulmonary cells from CBDL mice (at 2 weeks after operation) compared with those from control mice (Fig 1, B and C) . The results were further verified in triplicate experiments. The 3 different proteins were identified as SerpinB1a (48 kDa), ANXA1 (46 kDa), and S100A9 (16 kDa) by MALDI-TOF MS in accordance with their molecular masses (Table) . In this study, we focused on the roles of these 3 proteins because only these 3 spots were repeatedly increased in CBDL mice and clearly detected with high accuracy by MS analyses.
Since these proteins are well-known inflammation-induced factors, we performed additional protein analyses to investigate the roles of these proteins in the mechanism of lung injury after CBDL. To confirm the upregulation of the proteins, we performed Western blot analyses using anti-SerpinB1a, anti-ANXA1, and anti-S100A9 antibodies. As expected, single bands corresponding to the molecular mass of each protein were significantly upregulated in CD31-expressing pulmonary cells from CBDL mice (2 weeks after operation; Fig 1, D) .
Subsequently, to investigate the time course of protein production, whole lung tissues were harvested from each group at 2, 3, and 4 weeks after operation. Interestingly, at all time points, SerpinB1a and S100A9 proteins exhibited higher expression in whole lung lysates from CBDL mice than in those from sham mice (Fig 1, E) , in which expression was barely detectable. Additionally, ANXA1 proteins were not detectable in whole lung lysates during the same period (data not shown). These data indicated that Serpin B1a, ANXA1, and S100A9 were induced strongly in lungs after the occurrence of liver damage and that the increased expression of SerpinB1a and S100A9 proteins persisted during the 2-to 4-week period after CBDL.
Immunohistochemical analyses of SerpinB1a, S100A9, and ANXA1 in the lungs. To clarify the localization of the 3 identified proteins in the lungs, we performed immunohistochemical staining. As shown in Fig 2, A, S100A9 was more highly expressed in CBDL mice. In contrast, SerpinB1a was mainly localized to the tracheal epithelial cell layers in both CBDL and sham mice (data not shown). Interestingly, only in CBDL mice, this protein was strongly localized with lymphocytes and monocytes (Fig 2, B) . We also found that ANXA1 was highly detected in lymphocytes and monocytes of CBDL mice (2 weeks after operation) compared with that in sham mice (Fig 2, C) . Similar results were obtained at 3 and 4 weeks after CBDL (data not shown). These results indicated that SerpinB1a, S100A9, and ANXA1 were highly expressed in leukocytes associated with proliferated and dilated pulmonary vascular endothelial cells, as determined by hematoxylin and eosin (HE) staining in CBDL mice.
Quantification of SerpinB1a, S100A9, and ANXA1 mRNAs in various tissues. Based on our findings regarding increased numbers of SerpinB1a-, S100A9-, and ANXA1-positive pulmonary cells after 2 weeks, we assumed that mRNA synthesis for these genes may be accelerated within 2 to 4 weeks after CBDL. To examine the correlations between the mRNA expression and protein production for the 3 genes identified in this study, we performed qRT-PCR analyses. S100A9 mRNA levels were significantly increased in CBDL mice compared with that in sham mice (Fig 3, A) . The highest elevation in S100A9 mRNA expression was observed at 4 weeks after CBDL, with an approximate 30-fold increase in mRNA levels compared with that of the sham group (Fig 3,  A) . Moreover, ANXA1 mRNA expression was also increased 1.5-fold in CBDL mice at all time points (Fig 3, B) .
Importantly, these data were consistent with the immunohistochemical staining patterns. The mRNA levels of SerpinB1a, however, remained unchanged by CBDL at all time points (Fig 3, C) .
Based on these findings, we hypothesized that only the SerpinB1a mRNA was synthesized and subsequently translated into protein in organs other than the lungs and then transported to the lungs. To test this hypothesis, we harvested the spleen, heart, and liver tissues of the mice at 4 weeks after CBDL and evaluated protein production and mRNA expression for the 3 targets using Western blotting and qRT-PCR. The results showed that SerpinB1a protein levels clearly increased after CBDL in all tissues, particularly in the spleen and liver (Fig 4, A) . qRT-PCR analyses showed that SerpinB1a mRNA was increased 4-fold in the livers of CBDL mice compared with that in sham mice (Fig 4,  B) . These data suggested that SerpinB1a protein may mainly be synthesized in the liver and may then be transported to various tissues, such as the lung, heart, and spleen.
Localization of S100A9, SerpinB1a, and ANXA1 in the livers of mice after CBDL. Our results showed that the mRNA levels of the 3 identified proteins were dramatically increased in the livers of mice after CBDL, with SerpinB1a showing strong upregulation after operation. Therefore, we next performed histochemical analyses to identify liver cells expressing SerpinB1a. Inflammatory cell invasion and collagen deposition in liver tissues of CBDL mice were identified by HE staining and Masson's Trichrome staining (Fig 5, A and B) .
Cirrhosis-specific histologic findings, however, such as severe bridging fibrosis, were not observed in the liver tissues of CBDL mice. Additionally, SerpinB1a-positive blood cells, such as monocytes and/or macrophages (Kupffer cells) in the liver sinusoid, were strongly stained at 3 weeks after CBDL (Fig 5, C) . Western blot analysis revealed that SerpinB1a was present in the serum of mice after CBDL (Fig 5, D) . These data suggested that SerpinB1a secreted from the liver may play a key role in regulating the immune response during lung injury (Fig 6) .
DISCUSSION
We previously established a lung injury mouse model with CBDL; in this model, mice showed pulmonary microvascular dilatation and deterioration of arterial oxygenation. 7 We found an increase in the number of CD31-positive cells, which are primarily vascular endothelial cells. Moreover, the lung pathology of mice in our model was different from that of rat models when we analyzed gene expression profiles using a microarray. The expression of the TNF-a gene and its downstream molecules dramatically increased in pulmonary vascular cells after CBDL, whereas vascular endothelial growth factor signaling components were not altered. In this study, we aimed to further elucidate the molecular mechanisms and pathology of CBDL at the protein level by proteomic analyses. Our results identified S100A9, SerpinB1a, and ANXA1 as CBDL-inducible proteins. S100A9 is a proinflammatory cytoplasmic protein that plays key roles in leukocyte behavior during inflammation, such as secretion of chemokine and cytokine, and regulation of cell adhesion and migration. [11] [12] [13] Additionally, S100A9 functions as a biomarker of inflammatory bowel disease and is highly expressed in neutrophils and monocytes in inflamed tissues.
14,15 A recent study using S100A9-knockout mice in an in vivo model of rodent acute liver injury induced by CCl 4 injection showed that S100A9 plays essential roles in neutrophil recruitment in liver tissues. 16 Additionally, S100A9 forms heterodimers with Quantitative RT-PCR analysis of representative genes identified with 2D gel electrophoresis. S100A9 (A), ANXA1 (B), and SerpinB1a (C) mRNA were quantified in whole tissues from sham-operated mice and CDBL mice at 2, 3, and 4 weeks after ligation. Error bars indicate means ± standard errors (n = 3). S100A8, known as calprotectin (S100A8/A9), which can induce neutrophil chemotaxis, adhesion, and activation via spleen tyrosine kinase, phosphoinositol 3-kinase/AKT, and extracellular signal-regulated kinase. 17 The mRNA levels of S100 genes are strongly induced by proinflammatory cytokines, such as TNF-a, and both proteins regulate the transendothelial migration of leukocytes in humans. 18 The important aspect to note is that previously, our microarray data in CD31-positive cells containing endothelial cells, which were taken from CBDL mice, showed that mRNA levels of TNF-a and TNF-a-inducible molecules containing S100A9 and S100A8 considerably increased. 7 Furthermore, our data also showed that the localization of S100A9 protein in neutrophils was consistent with that in pulmonary endothelial cells. These findings may help explain the crucial roles of S100A9 in neutrophil migration associated with the pathologic processes of dilating pulmonary endothelial cells after CBDL.
Serpins have inhibitory activities against serine and/or cysteine proteases and regulate crucial intra-and extracellular proteolytic events, including neutrophil invasion, complement activation, and blood coagulation. 19 Serpins are a superfamily of 45-kDa proteins with a highly conserved structure. SerpinB1 has 4 homologs in mice, ie, SerpinB1a, SerpinB1b, SerpinB1c, and SerpinB1d. SerpinB1a is the ortholog of human SerpinB1 20 and acts as an inhibitor of protease activity in inflamed tissues. 21 In this study, we found that SerpinB1a was expressed in lung tissue after CBDL. Immunohistochemical analyses showed that the location of SerpinB1a in monocytes was consistent with that in vascular cells. Moreover, we also found that lung SerpinB1a was primarily synthesized in the liver and secreted into the serum. During inflammation, neutrophils secrete elastase, which is a serine proteinase belonging to the same family as chymotrypsin. 22 While this neutrophil protease is a physiologic key molecule in killing and clearance of pathogens, excessive secretion of the proteases can damage the host tissues and impair the removal of apoptotic cells in chronic inflammations.
23,24
Fig 4. Detection of identified proteins in tissue lysates of whole lung, heart, spleen, and liver tissues. (A) Western blot analysis of SerpinB1a was performed in the lung, heart, spleen, and liver tissues of CBDL (CBDL; for 3 weeks) and sham mice (sham). GAPDH was used as a positive control. Quantitative RT-PCR for SerpinB1a was performed in whole liver (B), heart (C), and spleen tissues (D) of sham and CBDL mice. Error bars indicate means ± standard errors (n = 3). ***P < .001 (CBDL versus sham).
In our study, we found that more Ly6G-positive neutrophils were located in dilated pulmonary vascular cells 2 and 3 weeks after operation compared with that in control mice. 7 Taken together, these results and the results of previous studies suggested that SerpinB1a in the serum or on monocytes may protect host cells from CBDLinduced pulmonary tissue damage caused by the proteolytic activity of neutrophil elastase (Fig 6) .
In this study, we also identified ANXA1 protein in lung tissues obtained from CBDL mice using 2D gel electrophoresis combined with MS analysis. Further immunohistochemical analysis of the lungs revealed that ANXA1-positive cells were increased dramatically in populations of neutrophils and monocytes. ANXA1 is a member of the annexin superfamily of calcium-binding proteins and is expressed primarily in neutrophils, eosinophils, and monocytes. [25] [26] [27] [28] Several studies have shown that this protein is involved in the adhesion and migration of leukocytes during the development of the inflammatory response. Recently, ANXA1 has also been found to be upregulated in the context of various insults to the lung, including tumors, 29, 30 and in acute 31 and chronic 26 inflammation as well as leukocyte migration. 32 A recent study showed that ANXA1 is responsible for leukocyte behaviors, such as detachment of adherent leukocytes from the endothelium and L-selection shedding by neutrophils in the development of the inflammatory response. 33 Interestingly, the released C-terminal domain of ANXA1 from activated neutrophils contributes to neutrophil transmigration by promoting clustering of intracellular adhesion molecule-1 on the endothelial cell surface around migrating neutrophils. 32 Taken together, these results suggested that ANXA1 produced from monocytes and neutrophils may play an important role in regulating migration and recruitment of leukocytes on endothelial cells after lung injury in CBDL mice. In contrast, ANXA1 protein and mRNA levels decreased in CBDL rats. 34 Moreover, overexpression of the ANXA1 genes inhibits the proliferation of pulmonary microvascular endothelial cells induced with CBDL rat serum.
Another study, however, showed that ANXA1 is a key regulator of pathologic angiogenesis and the physiologic angiogenic balance in mice. 35, 36 Additionally, ANXA1 is highly and specifically expressed in tumor endothelial cells of the lungs. 30 In addition, ANXA1-null mice show reduced tumor growth, metastasis, angiogenesis, and wound healing. 36 Therefore, these findings suggest that ANXA1 plays important roles in promotion of angiogenesis in CBDL mice, which are different from those of rat models.
In conclusion, we have successfully identified 3 pulmonary pathogenesis-related proteins, S100A9, SerpinB1a, and ANXA1, in CBDL mice. We also analyzed the mRNA expression levels and localization of these targets. Future experiments using knockout mice are necessary to clarify the roles of these proteins in liver damage-induced lung injury. In addition, more high-resolution approaches, such as liquid chromatography-MS/MS, will be useful to clarify the global protein signal network in future studies. Our findings contribute to the accumulating evidence linking lung injury with liver dysfunction in humans and may provide insights into the development of efficacious therapies for treating and preventing liver damage. Schematic illustration of the molecular mechanism. After liver injury, the expression levels of TNF-a and its downstream molecules are strongly upregulated in pulmonary endothelial cells. Consequently, S100A9 and ANXA1 are also induced in endothelial cells and neutrophils, mediating migration and recruitment of leukocytes. SerpinB1a, derived from the liver, plays a key role in the protection of host cells, such as endothelial cells, from leukocyte proteases involved in inflammation.
